臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"wu chou"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 1-25 of 49 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
國立成功大學	2023-12	Clinical implications of PNA-sequencing as a complementary test for EGFR mutation analysis in human lung cancer	Chen;Yi-Lin;Lin;Chien-Chung;Yu;Yu-Ting;Chen;Wan-Li;Yang;Shu-Ching;Huang;Wenya;Su;Wu-Chou;Chow;Nan-Haw;Ho;Chung-Liang
國立成功大學	2023-11-2	Distinct Features of Plasma Ultrashort Single-Stranded Cell-Free DNA as Biomarkers for Lung Cancer Detection	Cheng;Jordan;Swarup;Neeti;Li;Feng;Kordi;Misagh;Lin;Chien-Chung;Yang;Szu-Chun;Huang;Wei-Lun;Aziz;Mohammad;Kim;Yong;Chia;David;Yeh;Yu-Min;Wei;Fang;Zheng;David;Zhang;Liying;Pellegrini;Matteo;Su;Wu-Chou;Wong;David, T. W.
國立成功大學	2023-06-23	Concise nanotherapeutic modality for cancer involving graphene oxide dots in conjunction with ascorbic acid	Shih;Chun-Yan;Wang;Pei-Ting;Chung;Wei-Pang;Wang;Wen-Hsiu;Chiang;I-Ting;Su;Wu-Chou;Huang;Wei-Lun;Teng;Hsisheng
國立成功大學	2023-03-9	Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs	Chu;Chang-Yao;Lin;Chien-Yu;Lin;Chien-Chung;Li;Chien-Feng;Wu;Shang-Yin;Tsai;Jeng-Shiuan;Yang;Szu-Chun;Chen;Chian-Wei;Lin;Chia-Yin;Chang;Chao-Chun;Yen;Yi-Ting;Tseng;Yau-Lin;Su;Po-Lan;Su;Wu-Chou
國立成功大學	2022-11	Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio	Tsai;Jeng-Shiuan;Wei;Sheng-Huan;Chen;Chian-Wei;Yang;Szu-Chun;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2022-08-11	Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation	Chin;Yu-Cheng;Yang;Li-Xing;Hsu;Fei-Ting;Hsu;Che-Wei;Chang;Te-Wei;Chen;Hsi-Ying;Chen;Linda, Yen-Chien;Chia;Chun, Zi;Hung;Chun-Hua;Su;Wu-Chou;Chiu;Yi-Chun;Huang;Chih-Chia;Liao;Mei-Yi
國立成功大學	2022-08	Development of a cancer cells self-activating and miR-125a-5p expressing poly-pharmacological nanodrug for cancer treatment	Chang;Yung-Chieh;Shieh;Min-Chieh;Chang;Yen-Hsuan;Huang;Wei-Lun;Su;Wu-Chou;Cheng;Fong-Yu;Cheung;Antonio, Chun Hei
國立成功大學	2022-05-20	Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naive Metastatic Lung Adenocarcinoma	Yang;Szu-Chun;Lin;Chien-Chung;Chen;Yi-Lin;Su;Wu-Chou
國立成功大學	2022-02-28	The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy	Su;Po-Lan;Chen;Jung-Yueh;Chu;Chang-Yao;Chen;Yi-Lin;Chen;Wan-Li;Lin;Kuan-Yu;Ho;Chung-Liang;Tsai;Jeng-Shiuan;Yang;Szu-Chun;Chen;Chian-Wei;Wu;Yi-Lin;Tseng;Yau-Lin;Chang;Chao-Chun;Yen;Yi-Ting;Lin;Chia-Ying;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2022-01-7	FTY720 in resistant human epidermal growth factor receptor 2-positive breast cancer	Chung;Wei-Pang;Huang;Wei-Lun;Liao;Wei-An;Hung;Chun-Hua;Chiang;Chi-Wu;Cheung;Antonio, Chun Hei;Su;Wu-Chou
國立成功大學	2022-01	Improved survival in patients with unresectable stage III EGFR-mutant adenocarcinoma with upfront EGFR-tyrosine kinase inhibitors	Wang;Sheng-Yuan;Lai;Ching-Han;Chen;Chian-Wei;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2022	PI3K inhibitors in trastuzumab-resistant HER2-positive breast cancer cells with PI3K pathway alterations	Chung;Wei-Pang;Huang;Wei-Lun;Lee;Chun-Hui;Hsu;Hui-Ping;Huang;Wan-Ling;Liu;You-Yu;Su;Wu-Chou
國立成功大學	2022	Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy	Yang;Pei-Shan;Yu;Min-Hua;Hou;Ya-Chin;Chang;Chih-Peng;Lin;Shao-Chieh;Kuo;I-Ying;Su;Pei-Chia;Cheng;Hung-Chi;Su;Wu-Chou;Shan;Yan-Shen;Wang;Yi-Ching
國立成功大學	2021-12	Association between Altered Oncogenic Signaling Pathways and Overall Survival of Patients with Metastatic Colorectal Cancer	Huang;Yi-Hsuan;Lin;Peng-Chan;Su;Wu-Chou;Chan;Ren-Hao;Chen;Po-Chuan;Lin;Bo-Wen;Shen;Meng-Ru;Chen;Shang-Hung;Yeh;Yu-Min
國立成功大學	2021-11	CD40 Pathway and IL-2 Expression Mediate the Differential Outcome of Colorectal Cancer Patients with Different CSF1R c.1085 Genotypes	Yeh;Yu-Min;Lin;Peng-Chan;Su;Wu-Chou;Shen;Meng-Ru
國立成功大學	2021-09-24	Development of a novel ALK rearrangement screening test for non-small cell lung cancers	Chen;Yi-Lin;Chen;Wan-Li;Cheng;Yi-Chia;Lin;Ming-Ching;Yang;Shu-Ching;Tsai;Hung-Wen;Lin;Chien-Chung;Su;Wu-Chou;Chow;Nan-Haw;Ho;Chung-Liang
國立成功大學	2021-09	EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis	Tsai;Jeng-Shiuan;Su;Po-Lan;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Lai;Wu-Wei;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2021-05-14	Biocompatible hole scavenger-assisted graphene oxide dots for photodynamic cancer therapy	Shih;Chun-Yan;Huang;Wei-Lun;Chiang;I-Ting;Su;Wu-Chou;Teng;Hsisheng
國立成功大學	2021-04	Development of the CK-MB-1 trastuzumab-resistant HER2-positive breast cancer cell line and xenograft animal models	Chung;Wei-Pang;Huang;Wei-Lun;Liao;Wei-An;Huang;Wan-Ling;Liu;You-Yu;Su;Wu-Chou
國立成功大學	2021-03-1	Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors	Tsai;Hui-Jen;Shiah;Her-Shyong;Chang;Jang-Yang;Su;Wu-Chou;Chiang;Nai-Jung;Chen;Li-Tzong
國立成功大學	2021-03	Extracellular Vesicle miR-200c Enhances Gefitinib Sensitivity in Heterogeneous EGFR-Mutant NSCLC	Lin;Chien-Chung;Wu;Chin-You;Tseng;Joseph, Ta-Chien;Hung;Chun-Hua;Wu;Shang-Yin;Huang;Yu-Ting;Chang;Wei-Yuan;Su;Po-Lan;Su;Wu-Chou
國立成功大學	2021-02	First-line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation-positive non-small cell lung cancer	Su;Po-Lan;Chen;Chian-Wei;Wu;Yi-Lin;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2021-02	Nanomedicine-Based Strategies Assisting Photodynamic Therapy for Hypoxic Tumors: State-of-the-Art Approaches and Emerging Trends	Shih;Chun-Yan;Wang;Pei-Ting;Su;Wu-Chou;Teng;Hsisheng;Huang;Wei-Lun
國立成功大學	2021	Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment	Kuo;I-Ying;Yang;You-En;Yang;Pei-Shan;Tsai;Yu-Jou;Tzeng;Hong-Tai;Cheng;Hung-Chi;Kuo;Wan-Ting;Su;Wu-Chou;Chang;Chih-Peng;Wang;Yi-Ching
國立成功大學	2020-10	Clinical Frailty Scale in Predicting Postoperative Outcomes in Older Patients Undergoing Curative Surgery for Urologic Malignancies: A Prospective Observational Cohort Study	Sun;Chien-Yao;Huang;Chien-Cheng;Tsai;Yuh-Shyan;Chang;Yu-Tzu;Ou;Chien-Hui;Su;Wu-Chou;Fan;Sheng-Yu;Wang;Shan-Tair;Yang;Deng-Chi;Huang;Chi-Chang;Chang;Chia-Ming

Showing items 1-25 of 49 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2826208
	???header.visitor??? : 31902040 ???header.onlineuser??? : 1374 ???header.sponsordeclaration???